SCIBAC INC.

Milpitas, CA · Founded 2015 · CIK 0001648437 · Biotech · Private

Live biotherapeutic microbes engineered via DRIVE platform to treat cystic fibrosis-associated nontuberculous mycobacterial lung infections

scibac.com →
Grants
$573K
2 awards
Sector median: 1
Raised
—
1 Form D · Jul 2015
135 months since last filing
Contracts
—
No federal contracts on record
Patents
7
1 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Live biotherapeutics for the treatment of nontuberculous mycobacteria lung infection associated with cystic fibrosis$286,530
Federal grantDepartment of Health and Human Services · Phase I · Live biotherapeutics for the treatment of nontuberculous mycobacteria lung infection associated with cystic fibrosis$286,530
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1792Green Growth Brands Inc.—$17M
1793PMed Holdings, LLC—$1.6M
1794Mekanistic Therapeutics, LLC——
1795SCIBAC INC.——
1796NATSAR PHARMACEUTICALS, INC.—$4.2M
1797vTv Therapeutics Holdings LLC——
1798Arbor Plastic Technologies, LLC—$910K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Anthony CannDirector · Executive Officer · Promoter
  • Lawrence FryDirector · Executive Officer · Promoter
  • Jeanette MuchaDirector · Executive Officer · Promoter
  • Derik TwomeyDirector · Promoter

Patents

USPTO · 1 granted of 7
  • Live Biotherapeutics to Treat and Prevent Lung Conditionsapplication
  • Method for Producing Chimeric Microbial Hybridsapplication
  • Method for Producing Chimeric Microbial Hybridsapplication
  • Method for Producing Chimeric Microbial Hybridsgranted
  • Live Biotherapeutics to Treat and Prevent Lung Conditionsapplication
  • Live Biotherapeutics To Treat And Prevent Lung Conditionsapplication
  • A Method For Producing Chimeric Microbial Hybridsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.